Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.

Autor:	Dhakal S; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Ruiz-Bedoya CA; Department of Pediatrics, The Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35grid.471401.7grid.21107.35grid.471401.7 School of Medicine, Baltimore, Maryland, USA., Zhou R; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Creisher PS; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Villano JS; Department of Molecular and Comparative Pathobiology, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Littlefield K; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Ruelas Castillo J; Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Marinho P; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Jedlicka AE; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Ordonez AA; Department of Pediatrics, The Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35grid.471401.7grid.21107.35grid.471401.7 School of Medicine, Baltimore, Maryland, USA., Bahr M; Department of Pediatrics, The Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35grid.471401.7grid.21107.35grid.471401.7 School of Medicine, Baltimore, Maryland, USA., Majewska N; Advanced Mammalian Biomanufacturing Innovation Center, Department of Chemical and Biomolecular Engineering, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35grid.471401.7grid.21107.35grid.471401.7, Baltimore, Maryland, USA., Betenbaugh MJ; Advanced Mammalian Biomanufacturing Innovation Center, Department of Chemical and Biomolecular Engineering, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35grid.471401.7grid.21107.35grid.471401.7, Baltimore, Maryland, USA., Flavahan K; Department of Pediatrics, The Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35grid.471401.7grid.21107.35grid.471401.7 School of Medicine, Baltimore, Maryland, USA., Mueller ARL; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Looney MM; Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Quijada D; Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Mota F; Department of Pediatrics, The Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35grid.471401.7grid.21107.35grid.471401.7 School of Medicine, Baltimore, Maryland, USA., Beck SE; Department of Molecular and Comparative Pathobiology, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Brockhurst J; Department of Molecular and Comparative Pathobiology, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Braxton AM; Department of Molecular and Comparative Pathobiology, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Castell N; Department of Molecular and Comparative Pathobiology, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Stover M; Department of Molecular and Comparative Pathobiology, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., D'Alessio FR; Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Metcalf Pate KA; Department of Molecular and Comparative Pathobiology, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Karakousis PC; Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Mankowski JL; Department of Molecular and Comparative Pathobiology, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Pekosz A; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Department of Molecular and Comparative Pathobiology, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Jain SK; Department of Pediatrics, The Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35grid.471401.7grid.21107.35grid.471401.7 School of Medicine, Baltimore, Maryland, USA., Klein SL; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Jazyk:	angličtina
Zdroj:	MBio [mBio] 2021 Aug 31; Vol. 12 (4), pp. e0097421. Date of Electronic Publication: 2021 Jul 13.
DOI:	10.1128/mBio.00974-21
Abstrakt:	In the coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more severe outcomes are reported in males than in females, including hospitalizations and deaths. Animal models can provide an opportunity to mechanistically interrogate causes of sex differences in the pathogenesis of SARS-CoV-2. Adult male and female golden Syrian hamsters (8 to 10 weeks of age) were inoculated intranasally with 10 5 50% tissue culture infective dose (TCID 50 ) of SARS-CoV-2/USA-WA1/2020 and euthanized at several time points during the acute (i.e., virus actively replicating) and recovery (i.e., after the infectious virus has been cleared) phases of infection. There was no mortality, but infected male hamsters experienced greater morbidity, losing a greater percentage of body mass, developed more extensive pneumonia as noted on chest computed tomography, and recovered more slowly than females. Treatment of male hamsters with estradiol did not alter pulmonary damage. Virus titers in respiratory tissues, including nasal turbinates, trachea, and lungs, and pulmonary cytokine concentrations, including interferon-β (IFN-β) and tumor necrosis factor-α (TNF-α), were comparable between the sexes. However, during the recovery phase of infection, females mounted 2-fold greater IgM, IgG, and IgA responses against the receptor-binding domain of the spike protein (S-RBD) in both plasma and respiratory tissues. Female hamsters also had significantly greater IgG antibodies against whole-inactivated SARS-CoV-2 and mutant S-RBDs as well as virus-neutralizing antibodies in plasma. The development of an animal model to study COVID-19 sex differences will allow for a greater mechanistic understanding of the SARS-CoV-2-associated sex differences seen in the human population. IMPORTANCE Men experience more severe outcomes from coronavirus disease 2019 (COVID-19) than women. Golden Syrian hamsters were used to explore sex differences in the pathogenesis of a human isolate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). After inoculation, male hamsters experienced greater sickness, developed more severe lung pathology, and recovered more slowly than females. Sex differences in disease could not be reversed by estradiol treatment in males and were not explained by either virus replication kinetics or the concentrations of inflammatory cytokines in the lungs. During the recovery period, antiviral antibody responses in the respiratory tract and plasma, including to newly emerging SARS-CoV-2 variants, were greater in female than in male hamsters. Greater lung pathology during the acute phase combined with lower antiviral antibody responses during the recovery phase of infection in males than in females illustrate the utility of golden Syrian hamsters as a model to explore sex differences in the pathogenesis of SARS-CoV-2 and vaccine-induced immunity and protection.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu